Evidence map›Paper›PMID 32107375›Full record

ArticleNature communications2020

A combined experimental and modelling approach for the Weimberg pathway optimisation.

Lu Shen, Martha Kohlhaas, Junichi Enoki, Roland Meier, Bernhard Schönenberger, Roland Wohlgemuth, Robert Kourist, Felix Niemeyer, David van Niekerk, Christopher Bräsen and 3 more

Abstract readValidation Study
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Article
  2. Review
  3. EngineeringSynthetic and systems biotechnology · 2026
    Article
  4. Article
  5. Multi-layered metabolic remodeling ofMetabolic engineering communications · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Metabolic bottlenecks ofMetabolic engineering communications · 2024
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Xylo-Oligosaccharide Utilization by EngineeredFrontiers in bioengineering and biotechnology · 2022
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Lu ShenMolecular Enzyme Technology and Biochemistry (MEB), Environmental Microbiology and Biotechnology (EMB), Centre for Water and Environmental Research (CWE), University of Duisburg-Essen, Universitaetsstrasse 5, 45141, Essen, Germany.
Martha KohlhaasInstitute of Organic Chemistry and Center for Nanointegration Duisburg-Essen (CENIDE), University of Duisburg-Essen, Universitaetsstrasse 7, 45117, Essen, Germany.
Junichi EnokiJunior Research Group for Microbial Biotechnology, Ruhr-University Bochum, Universitaetsstrasse 150, 44780, Bochum, Germany.
Roland MeierMember of Merck Group, Sigma-Aldrich, Industriestrasse 25, Buchs, 9471, Switzerland.
Bernhard SchönenbergerMember of Merck Group, Sigma-Aldrich, Industriestrasse 25, Buchs, 9471, Switzerland.
Roland WohlgemuthMember of Merck Group, Sigma-Aldrich, Industriestrasse 25, Buchs, 9471, Switzerland.ORCID http://orcid.org/0000-0001-6166-3228
Robert KouristJunior Research Group for Microbial Biotechnology, Ruhr-University Bochum, Universitaetsstrasse 150, 44780, Bochum, Germany.ORCID http://orcid.org/0000-0002-2853-3525
Felix NiemeyerInstitute of Organic Chemistry and Center for Nanointegration Duisburg-Essen (CENIDE), University of Duisburg-Essen, Universitaetsstrasse 7, 45117, Essen, Germany.ORCID http://orcid.org/0000-0002-9145-773X
David van NiekerkDepartment of Biochemistry, University of Stellenbosch, Private Bag X1, Matieland, 7602, South Africa.
Christopher BräsenMolecular Enzyme Technology and Biochemistry (MEB), Environmental Microbiology and Biotechnology (EMB), Centre for Water and Environmental Research (CWE), University of Duisburg-Essen, Universitaetsstrasse 5, 45141, Essen, Germany.
Jochen NiemeyerInstitute of Organic Chemistry and Center for Nanointegration Duisburg-Essen (CENIDE), University of Duisburg-Essen, Universitaetsstrasse 7, 45117, Essen, Germany. jochen.niemeyer@uni-due.de.ORCID http://orcid.org/0000-0002-9295-4260
Jacky SnoepDepartment of Biochemistry, University of Stellenbosch, Private Bag X1, Matieland, 7602, South Africa. jls@sun.ac.za.ORCID http://orcid.org/0000-0002-0405-8854
Bettina SiebersMolecular Enzyme Technology and Biochemistry (MEB), Environmental Microbiology and Biotechnology (EMB), Centre for Water and Environmental Research (CWE), University of Duisburg-Essen, Universitaetsstrasse 5, 45141, Essen, Germany. bettina.siebers@uni-due.de.ORCID http://orcid.org/0000-0002-9905-541X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The oxidative Weimberg pathway for the five-step pentose degradation to α-ketoglutarate is a key route for sustainable bioconversion of lignocellulosic biomass to added-value products and biofuels. The oxidative pathway from Caulobacter crescentus has been employed in in-vivo metabolic engineering with intact cells and in in-vitro enzyme cascades. The performance of such engineering approaches is often hampered by systems complexity, caused by non-linear kinetics and allosteric regulatory mechanisms. Here we report an iterative approach to construct and validate a quantitative model for the Weimberg pathway. Two sensitive points in pathway performance have been identified as follows: (1) product inhibition of the dehydrogenases (particularly in the absence of an efficient NAD

Indexed as

BioreactorsModels, ChemicalBacterial ProteinsBiofuelsCarbohydrate MetabolismCaulobacter crescentusComputer SimulationHydro-LyasesKetoglutaric AcidsMetabolic EngineeringMetabolic Networks and PathwaysNADPOxidation-ReductionOxidoreductasesXyloseBacterial ProteinsBiofuelsHydro-LyasesKetoglutaric AcidsNADPOxidoreductasesXylose

Identifiers

PMID32107375
PMCPMC7046635

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.